SCHEMBL5459432

SCHEMBL5459432

O=C(Nc1ccc(N2CCN(C(=O)Nc3ccc(OCCO)cc3C(F)(F)F)CC2)c(F)c1)Nc1ccccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 1/20 0.43
MTTP P55157 1/20 0.43
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PANK3 Q9H999 1/20 0.41
POLB P06746 1/20 0.41
TRPV1 Q8NER1 5/20 0.41
HRH3 Q9Y5N1 2/20 0.41
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR2C P28335 1/20 0.40
HTR6 P50406 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
EPHX2 P34913 1/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5466775 0.94 MAPT (0.45) NPY2RKMT2AKDM4EGAATRPV1
SCHEMBL5462771 0.78 KDM4E (0.46) KMT2AKDM4EGAAPOLBTRPV1
SCHEMBL5460458 0.77 P2RY1 (0.47) KDM4EGAATRPV1NPSR1HSD17B10
SCHEMBL5451314 0.76 CCNC (0.40) KDM4EGAAHSD17B10EPHX2LMNA
SCHEMBL5456051 0.75 MAPT (0.49) KMT2AGAAPOLBHTR1AHTR1D
SCHEMBL5470991 0.74 GAA (0.54) NPY2RMTTPKMT2AKDM4EGAA
SCHEMBL5460110 0.74 ALK (0.43) KMT2AGAAPOLBTRPV1HTR1A
SCHEMBL5459771 0.73 NPY2R (0.52) NPY2RMTTPKMT2AKDM4EGAA
SCHEMBL5455740 0.71 DGAT1 (0.40) KDM4EGAANPSR1HSD17B10LMNA
SCHEMBL5467434 0.69 GAA (0.55) NPY2RMTTPKMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NPY2R 2089/4885MTTP 595/4885KMT2A 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.